INVL Logo

Trakcja – Tiltra: Consolidated report for 6 mounths of...

The company Trakcja – Tiltra announced the news in Polish language. In order to avoid mistakes in translating a text of the message into the Lithuanian language, we recommend you..

More

Trakcja – Tiltra: Information about the conclusion of...

The company Trakcja – Tiltra announced the news in Polish language. In order to avoid mistakes in translating a text of the message into the Lithuanian language, we recommend you..

More

Trakcja – Tiltra: Information relating to the...

The company Trakcja – Tiltra announced the news in Polish language. In order to avoid mistakes in translating a text of the message into the Lithuanian language, we recommend you..

More

Trakcja – Tiltra: Information about an annex to a...

The Management Board of Trakcja – Tiltra S.A. (the “Company”) hereby informs that yesterday, i.e. on 31 August 2011, an annex was executed to the agreement of 18 November 2010..

More

A profit of Invalda group for the half of the year – 142.4...

During the first half of 2011 Invalda Group, one of the largest Lithuanian investment company’s, has earned 142.4 million LTL of net profit attributable to parent company. Majority of profit..

More

Results of Invalda AB group for 6 months of 2011

Results of Invalda AB group for 6 months of 2011:– part of consolidated profit attributable to shareholders of Invalda AB is 142.4 mln. LTL (41.2 mln. EUR);– the whole consolidated..

More

Notification on transaction concluded by manager of the...

Invalda AB received notification (attached) about transactions on the issuer’s securities, completed by the executive officer. Kristina GudauskaiteAssistant to President+370 52752776

More

Trakcja – Tiltra: Information about the conclusion of...

The Management Board of Trakcja – Tiltra S.A. (the “Company”) hereby announces that on 22 August 2011 it was informed by the Company’s subsidiary – Poldim S.A. with its registered..

More

Invalda for Sanitas’ shares will receive more than 90...

Invalda, one of the largest Lithuanian investment companies, will receive a total of 91.4 million EUR (315.7 million LTL) for the sale of Sanitas’ shares. Canadian company Valeant Pharmaceuticals International..

More